May 29, 2024 BRIDGEWATER, N.J. — Vyluma announced it has received approval from the European Medicines Agency (EMA) of its Marketing Authorization...
sponsored content November 1, 2023 By Erin S. Tomiyama, OD, PhD, FAAO Most compounding pharmacies are small and do not have the...
October 11, 2023 BRIDGEWATER, N.J. — Vyluma has released the results from the second stage of Phase III of its CHAMP (Childhood...
sponsored content August 15, 2023 By Kristen Dalli, Managing Editor, Review of Myopia Management ‘Pediatric ophthalmologists are the tip of the spear....
June 15, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE In a new study recently published in JAMA Ophthalmology, a novel preservative-free...
June 6, 2023 BRIDGEWATER, N.J. — The U.S. Food and Drug Administration (FDA) has accepted Vyluma’s new drug application (NDA) for its...
sponsored content June 1, 2023 By Kristen Dalli, Managing Editor, Review of Myopia Management At this year’s Global Specialty Lens Symposium, Mark...
sponsored content November 1, 2022 Review of Myopia Management’s Chief Medical Editor Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE, interviewed Vyluma executives...
sponsored content October 27, 2022 Vyluma aims to preserve the vision of a global population by providing meaningful and effective pharmaceutical ophthalmic...
September 1, 2022 BRIDGEWATER, N.J. — Vyluma has checked off an important step in its Phase III CHAMP (Childhood Atropine for Myopia...
June 14, 2022 BRIDGEWATER, N.J. — Vyluma and Laboratories Théa have entered into an exclusive licensing agreement for the registration and commercialization...
sponsored content January 3, 2022 By Neal Wolff, Vice President and Head of Marketing, Vylmua This year, awareness and understanding of myopia...
October 8, 2021 BRIDGEWATER, NJ — To show support for the International Agency for the Prevention of Blindness‘ (IAPB) 2021 World Sight...
sponsored content October 1, 2021 By Dwight Akerman, OD, MBA, FAAO, FBCLA Vyluma is dedicated to using its deep expertise to develop...
May 25, 2021 BRIDGEWATER, NJ — Nevakar has launched Vyluma, a new company that will create treatments for ophthalmic diseases such as...